Therefore, the aim of our work was to describe the distribution of transcription factor (NF-κβ), angiogenetic factor (VEGF), and remodeling markers (MMP-9 and TIMP-4) of the cholesteatoma. The gene discussed is MMP9; the disease is cholesteatoma.